Sirtris Pharmaceuticals, Inc. 4
4 · Sirtris Pharmaceuticals, Inc. · Filed May 31, 2007
Insider Transaction Report
Form 4
Sinclair David
Director
Transactions
- Conversion
Sereis C-1 Redeemable Convertible Preferred Stock
2007-05-29−14,881→ 0 total→ Common Stock (2,834 underlying) - Conversion
Series A Redeemable Convertible Preferred Stock
2007-05-29−50,000→ 0 total→ Common Stock (9,524 underlying) - Conversion
Common Stock
2007-05-29+2,834→ 162,834 total - Conversion
Common Stock
2007-05-29+9,524→ 160,000 total
Footnotes (2)
- [F1]Upon the closing of the Issuer's initial public offering, each 5.25 shares of Series A Redeemable Convertible Preferred Stock converted to 1 share of Common Stock.
- [F2]Upon the closing of the Issuer's initial public offering, each 5.25 shares of Series C-1 Redeemable Convertible Preferred Stock converted to 1 share of Common Stock.